THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Calls are mounting for revamp of FDA

By Diedtra Henderson
Globe Staff / December 25, 2004

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size – +

Just as the Enron scandal triggered an overhaul of corporate accounting practices, the nation's prescription drug crisis may prompt a sweeping revamp of the way the Food and Drug Administration ensures drug safety, some say. (Full article: 1213 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $4.95 1 article
  • $9.95 4 articles
  • $25.95 Monthly